Ignite Creation Date:
2025-12-25 @ 5:19 AM
Ignite Modification Date:
2025-12-26 @ 4:26 AM
Study NCT ID:
NCT03846427
Status:
COMPLETED
Last Update Posted:
2024-10-26
First Post:
2018-10-11
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Study of Zanubrutinib (BGB-3111) in Participants With Marginal Zone Lymphoma
Sponsor:
BeiGene
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-02-19
Start Date Type:
ACTUAL
Primary Completion Date:
2022-05-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-05-04
Completion Date Type:
ACTUAL
First Submit Date:
2018-10-11
First Submit QC Date:
None
Study First Post Date:
2019-02-19
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2022-01-14
Results First Submit QC Date:
None
Results First Post Date:
2022-03-03
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-23
Last Update Post Date:
2024-10-26
Last Update Post Date Type:
ACTUAL